Welcome to our dedicated page for Intuitive Surgical news (Ticker: ISRG), a resource for investors and traders seeking the latest updates and insights on Intuitive Surgical stock.
Intuitive Surgical Inc. (NASDAQ: ISRG), the pioneer of robotic-assisted minimally invasive surgery, provides critical updates through this comprehensive news hub. Track the latest developments surrounding the da Vinci Surgical System, regulatory milestones, and strategic initiatives shaping the future of surgical care.
This resource delivers verified press releases and financial updates essential for understanding ISRG's market position. Investors gain insights into earnings reports, partnership announcements, and technology advancements while medical professionals stay informed about clinical applications and procedural innovations.
Key content includes quarterly financial results, FDA clearances for new instruments, global expansion updates, and research collaborations advancing robotic surgery. All materials are sourced from official channels to ensure accuracy and compliance with financial disclosure standards.
Bookmark this page for real-time access to ISRG's evolving role in healthcare technology. Combine strategic awareness with operational knowledge through our curated collection of company-verified information.
Intuitive (Nasdaq: ISRG) reported strong Q1 2023 financial results, with revenue of $1.70 billion, a 14% increase compared to Q1 2022. The growth was driven by a 26% rise in da Vinci procedures despite ongoing COVID-19 disruptions in China. The company placed 312 da Vinci Surgical Systems, maintaining a steady growth of its installed base to 7,779 systems, a 12% increase year-over-year. Non-GAAP net income was $437 million, or $1.23 per diluted share, up from $413 million, or $1.13 per diluted share in Q1 2022. However, GAAP net income decreased slightly to $355 million from $366 million year-over-year. The company ended the quarter with $6.58 billion in cash and cash equivalents, reflecting share repurchases of $350 million.
Intuitive (Nasdaq: ISRG) announced fourth-quarter 2022 results, reporting revenue of $1.66 billion, a 7% increase from Q4 2021. Worldwide da Vinci procedures rose approximately 18%, but were affected by COVID-19 surges in China. The company placed 369 da Vinci Surgical Systems, down 4% from the previous year, while the installed base grew to 7,544 systems, a 12% increase.
GAAP net income was $325 million or $0.91 per diluted share, down from $381 million or $1.04 per share in Q4 2021. The company repurchased $1 billion in stock during the quarter, ending with $6.74 billion in cash and equivalents.
FAQ
What is the current stock price of Intuitive Surgical (ISRG)?
What is the market cap of Intuitive Surgical (ISRG)?
